HTR1B, ADIPOR1, PPARGC1A, and CYP19A1 and obesity in a Cohort of Caucasians and African Americans: An evaluation of gene-environment interactions and candidate genes

American Journal of Epidemiology

Volumn 175, Issue 1, 2012, Pages 11-21

  Edwards, Todd L ^a,b   Velez Edwards, Digna R ^a   Villegas, Raquel ^a,b   Cohen, Sarah S ^c   Buchowski, MacIej S ^a,d   Fowke, Jay H ^a,b,d   Schlundt, David ^d,f   Long, Ji Rong ^a,b,d   Cai, Qiuyin ^a,b,d   Zheng, Wei ^a,b,d   Shu, Xiao Ou ^a,b,d   Hargreaves, Margaret K ^d,e   Jeffrey, Smith ^a,d,f   Williams, Scott M ^b   Signorello, Lisa B ^a,c,d   Blot, William J ^a,c,d   Matthews, Charles E ^g  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^d VANDERBILT INGRAM CANCER CENTER   (United States)

^e MEHARRY MEDICAL COLLEGE   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

Author keywords

African continental ancestry group; body mass index; European continental ancestry group; genetics; molecular epidemiology; obesity

Indexed keywords

5 HYDROXYTRYPTAMINE RECEPTOR 1B; ADIPONECTIN RECEPTOR 1; AROMATASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; ALCOHOL; ANCESTRY; BODY MASS; COHORT ANALYSIS; GENOTYPE-ENVIRONMENT INTERACTION; MORBIDITY; OBESITY; POLYMORPHISM; SMOKING; WORLD HEALTH ORGANIZATION;

ADULT; AFRICAN AMERICAN; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CALORIC INTAKE; CAUCASIAN; CIGARETTE SMOKING; COHORT ANALYSIS; FEMALE; GENE INTERACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; ALCOHOL DRINKING; AROMATASE; BODY MASS INDEX; ENERGY INTAKE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; HEAT-SHOCK PROTEINS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, ADIPONECTIN; RISK FACTORS; SMOKING; TRANSCRIPTION FACTORS;

EUROPE;

EID: 84555170656     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr272     Document Type: Article

References (67)

1. World Health Organization. Global Database on Body Mass Index (BMI). Geneva, Switzerland: World Health Organization; 2009. (http://www.who.int/ mediacentre/factsheets/fs311/en/index.html). (Accessed June 6, 2010).
2. Field AE, Coakley EH, Must A, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 2001;161(13): 1581-1586. (Pubitemid 32681139)
3. Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA. 1999;282(16): 1523-1529. (Pubitemid 29504045)
4. Hjelmborg JB, Fagnani C, Silventoinen K, et al. Genetic influences on growth traits of BMI: a longitudinal study of adult twins. Obesity (Silver Spring). 2008;16(4):847-852. (Pubitemid 351465642)
5. Maes HH, Neale MC, Eaves LJ. Genetic and environmental factors in relative body weight and human adiposity. Behav Genet. 1997;27(4):325-351. (Pubitemid 27415169)
6. Wardle J, Carnell S, Haworth CM, et al. Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment. Am J Clin Nutr. 2008;87(2): 398-404. (Pubitemid 351226077)
7. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316(5826):889-894. (Pubitemid 46764279)
8. Loos RJ, Lindgren CM, Li S, et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet. 2008;40(6):768-775. (Pubitemid 351748863)
9. Meyre D, Delplanque J, Chèvre JC, et al. Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet. 2009;41(2):157-159.
10. Speliotes EK,Willer CJ, Berndt SI, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010;42(11):937-948.
11. Thorleifsson G, Walters GB, Gudbjartsson DF, et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet. 2009;41(1):18-24.
12. Willer CJ, Speliotes EK, Loos RJ, et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Genetic Investigation of Anthropometric Traits Consortium. Nat Genet. 2009;41(1):25-34.
13. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295(13):1549-1555.
14. Hetherington MM, Cecil JE. Gene-environment interactions in obesity. Forum Nutr. 2010;63:195-203.
15. Signorello LB, Hargreaves MK, Steinwandel MD, et al. Southern Community Cohort Study: establishing a cohort to investigate health disparities. J Natl Med Assoc. 2005;97(7): 972-979. (Pubitemid 40967401)
16. Buchowski MS, Schlundt DG, Hargreaves MK, et al. Development of a culturally sensitive food frequency questionnaire for use in the Southern Community Cohort Study. Cell Mol Biol (Noisy-le-Grand). 2003;49(8):1295-1304.
17. Signorello LB, Munro HM, Buchowski MS, et al. Estimating nutrient intake from a food frequency questionnaire: incorporating the elements of race and geographic region. Am J Epidemiol. 2009;170(1):104-111.
18. Joshipura KJ, Hu FB, Manson JE, et al. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med. 2001;134(12):1106- 1114.
19. Thorisson GA, Smith AV, Krishnan L, et al. The International HapMap Project Web site. Genome Res. 2005;15(11): 1592-1593. (Pubitemid 41545013)
20. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-575. (Pubitemid 47330214)
21. Price AL, Patterson NJ, Plenge RM, et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38(8):904-909. (Pubitemid 44141658)
22. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics. 2000; 155(2):945-959. (Pubitemid 30397141)
23. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med. 1990;9(7):811-818. (Pubitemid 20343989)
24. Togo P, Osler M, Sørensen TI, et al. Food intake patterns and body mass index in observational studies. Int J Obes Relat Metab Disord. 2001;25(12):1741-1751. (Pubitemid 33131913)
25. Hamblin MW, Metcalf MA, McGuffin RW, et al. Molecular cloning and functional characterization of a human 5-HT1B serotonin receptor: a homologue of the rat 5-HT1B receptor with 5-HT1D-like pharmacological specificity. Biochem Biophys Res Commun. 1992;184(2):752-759.
26. Jin H, Oksenberg D, Ashkenazi A, et al. Characterization of the human 5-hydroxytryptamine1B receptor. J Biol Chem. 1992;267(9):5735-5738.
27. Rocha BA, Scearce-Levie K, Lucas JJ, et al. Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor. Nature. 1998;393(6681):175- 178. (Pubitemid 28242258)
28. Lerer E, Kanyas K, Karni O, et al. Why do young women smoke? II. Role of traumatic life experience, psychological characteristics and serotonergic genes. Mol Psychiatry. 2006;11(8):771-781. (Pubitemid 44141810)
29. Sun HF, Chang YT, Fann CS, et al. Association study of novel human serotonin 5-HT(1B) polymorphisms with alcohol dependence in Taiwanese Han. Biol Psychiatry. 2002;51(11): 896-901. (Pubitemid 34521938)
30. Faraone SV, Perlis RH, Doyle AE, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57(11):1313- 1323. (Pubitemid 40798551)
31. Wang S, Zhang K, Xu Y, et al. An association study of the serotonin transporter and receptor genes with the suicidal ideation of major depression in a Chinese Han population. Psychiatry Res. 2009;170(2-3):204-207.
32. Levitan RD, Kaplan AS, Masellis M, et al. Polymorphism of the serotonin 5-HT1B receptor gene (HTR1B) associated with minimum lifetime body mass index in women with bulimia nervosa. Biol Psychiatry. 2001;50(8):640-643. (Pubitemid 33022652)
33. Denys D, Van Nieuwerburgh F, Deforce D, et al. Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial. J Clin Psychiatry. 2007;68(5):747-753. (Pubitemid 46841858)
34. Silva H, Iturra P, Solari A, et al. Fluoxetine response in impulsive-aggressive behavior and serotonin transporter polymorphism in personality disorder. Psychiatr Genet. 2010; 20(1):25-30.
35. Villafuerte SM, Vallabhaneni K, Sliwerska E, et al. SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A. Psychiatr Genet. 2009;19(6):281-291.
36. Fehr C, Grintschuk N, Szegedi A, et al. The HTR1B 861G〉C receptor polymorphism among patients suffering from alcoholism, major depression, anxiety disorders and narcolepsy. Psychiatry Res. 2000;97(1):1-10.
37. Hawi Z, Dring M, Kirley A, et al. Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT(1B) receptor gene in 273 nuclear families from a multi-centre sample. Mol Psychiatry. 2002; 7(7):718-725. (Pubitemid 34984949)
38. Huang YY, Oquendo MA, Friedman JM, et al. Substance abuse disorder and major depression are associated with the human 5-HT1B receptor gene (HTR1B) G861C polymorphism. Neuropsychopharmacology. 2003;28(1):163-169.
39. Soyka M, Preuss UW, Koller G, et al. Association of 5-HT1B receptor gene and antisocial behavior in alcoholism. J Neural Transm. 2004;111(1):101-109. (Pubitemid 38177821)
40. Harada N, Ogawa H, Shozu M, et al. Genetic studies to characterize the origin of the mutation in placental aromatase deficiency. Am J Hum Genet. 1992;51(3):666-672.
41. Okada Y, Kamatani Y, Takahashi A, et al. A genome-wide association study in 19 633 Japanese subjects identified LHX3-QSOX2 and IGF1 as adult height loci. Hum Mol Genet. 2010;19(11):2303-2312.
42. Ellis JA, Stebbing M, Harrap SB. Significant population variation in adult male height associated with the Y chromosome and the aromatase gene. J Clin Endocrinol Metab. 2001;86(9): 4147-4150. (Pubitemid 32848527)
43. Somner J, McLellan S, Cheung J, et al. Polymorphisms in the P450 c17 (17-hydroxylase/17,20-lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women. J Clin Endocrinol Metab. 2004;89(1):344-351. (Pubitemid 38183902)
44. Riancho JA, Valero C, Naranjo A, et al. Identification of an aromatase haplotype that is associated with gene expression and postmenopausal osteoporosis. J Clin Endocrinol Metab. 2007;92(2):660-665.
45. Cecil JE, Palmer CN, Fischer B, et al. Variants of the peroxisome proliferator-activated receptor gamma-and beta-adrenergic receptor genes are associated with measures of compensatory eating behaviors in young children. Am J Clin Nutr. 2007;86(1):167-173. (Pubitemid 47041607)
46. Ceni E, Crabb DW, Foschi M, et al. Acetaldehyde inhibits PPARc via H2O2-mediated c-Abl activation in human hepatic stellate cells. Gastroenterology. 2006;131(4): 1235-1252. (Pubitemid 44515101)
47. Festuccia WT, Oztezcan S, Laplante M, et al. Peroxisome proliferator-activated receptor-gamma-mediated positive energy balance in the rat is associated with reduced sympathetic drive to adipose tissues and thyroid status. Endocrinology. 2008;149(5):2121-2130. (Pubitemid 351574485)
48. Hollenberg AN, Susulic VS, Madura JP, et al. Functional antagonism between CCAAT/enhancer binding protein-alpha and peroxisome proliferator- activated receptor-gamma on the leptin promoter. J Biol Chem. 1997;272(8):5283-5290. (Pubitemid 27090091)
49. Puigserver P,Wu Z, Park CW, et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 1998;92(6):829-839. (Pubitemid 28155321)
50. Cowell RM, Blake KR, Russell JW. Localization of the transcriptional coactivator PGC-1a to GABAergic neurons during maturation of the rat brain. J Comp Neurol. 2007; 502(1):1-18. (Pubitemid 46481928)
51. Esterbauer H, Oberkofler H, Linnemayr V, et al. Peroxisome proliferator-activated receptor-gamma coactivator-1 gene locus: associations with obesity indices in middle-aged women. Diabetes. 2002;51(4):1281-1286. (Pubitemid 34438380)
52. Ridderstra°le M, Johansson LE, Rastam L, et al. Increased risk of obesity associated with the variant allele of the PPARGC1A Gly482Ser polymorphism in physically inactive elderly men. Diabetologia. 2006;49(3):496-500. (Pubitemid 43277872)
53. Weng SW, Lin TK,Wang PW, et al. Gly482Ser polymorphism in the peroxisome proliferator-activated receptor gamma coactivator-1a gene is associated with oxidative stress and abdominal obesity. Metabolism. 2010;59(4):581-586.
54. Gemma C, Sookoian S, Alvariñas J, et al. Maternal pregestational BMI is associated with methylation of the PPARGC1A promoter in newborns. Obesity (Silver Spring). 2009;17(5): 1032-1039.
55. Kim JH, Shin HD, Park BL, et al. Peroxisome proliferatoractivated receptor gamma coactivator 1 alpha promoter polymorphisms are associated with early-onset type 2 diabetes mellitus in the Korean population. Diabetologia. 2005;48(7): 1323-1330. (Pubitemid 41186097)
56. Kunej T, Globocnik Petrovic M, Dovc P, et al. A Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene is associated with type 2 diabetes in Caucasians. Folia Biol (Praha). 2004; 50(5):157-158. (Pubitemid 39545692)
57. Sun L, Yang Z, Jin F, et al. The Gly482Ser variant of the PPARGC1 gene is associated with type 2 diabetes mellitus in northern Chinese, especially men. Diabet Med. 2006; 23(10):1085-1092. (Pubitemid 44401137)
58. Zhang SL, Lu WS, Yan L, et al. Association between peroxisome proliferator-activated receptor-gamma coactivator-1a gene polymorphisms and type 2 diabetes in southern Chinese population: role of altered interaction with myocyte enhancer factor 2C. Chin Med J (Engl). 2007;120(21):1878-1885. (Pubitemid 350111060)
59. Francès F, Verdú F, Portolés O, et al. PPAR-alpha L162V and PGC-1 G482S gene polymorphisms, but not PPAR-gamma P12A, are associated with alcohol consumption in a Spanish Mediterranean population. Clin Chim Acta. 2008;398(1-2): 70-74.
60. Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003;423(6941):762-769. (Pubitemid 36735700)
61. Yamauchi T, Nio Y, Maki T, et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med. 2007;13(3):332-339. (Pubitemid 46376688)
62. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000;20(6): 1595-1599. (Pubitemid 30353893)
63. Kubota N, Terauchi Y, Yamauchi T, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem. 2002;277(29):25863- 25866. (Pubitemid 34967064)
64. Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 2002;8(7):731-737. (Pubitemid 34778727)
65. Iwabu M, Yamauchi T, Okada-Iwabu M, et al. Adiponectin and AdipoR1 regulate PGC-1a and mitochondria by Ca(2\+) and AMPK/SIRT1. Nature. 2010;464(7293):1313-1319.
66. Beebe-Dimmer JL, Zuhlke KA, Ray AM, et al. Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans. Prostate Cancer Prostatic Dis. 2010;13(4):362-368.
67. Stewart AL. The reliability and validity of self-reported weight and height. J Chronic Dis. 1982;35(4):295-309. (Pubitemid 12135365)